BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33193304)

  • 1. Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic Sclerosis.
    Leleu D; Levionnois E; Laurent P; Lazaro E; Richez C; Duffau P; Blanco P; Sisirak V; Contin-Bordes C; Truchetet ME
    Front Immunol; 2020; 11():532177. PubMed ID: 33193304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
    Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
    Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet Phagocytosis via P-selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis.
    Manfredi AA; Ramirez GA; Godino C; Capobianco A; Monno A; Franchini S; Tombetti E; Corradetti S; Distler JHW; Bianchi ME; Rovere-Querini P; Maugeri N
    Arthritis Rheumatol; 2022 Feb; 74(2):318-328. PubMed ID: 34279048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
    Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
    Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
    Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
    Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
    Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
    Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review of the Role of Microparticles in Systemic Sclerosis.
    Dunne JV; Bankole J; Keen KJ
    Curr Rheumatol Rev; 2013; 9(4):279-300. PubMed ID: 26932294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
    Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
    Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.
    Iversen LV; Ullman S; Østergaard O; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
    BMC Musculoskelet Disord; 2015 Aug; 16():191. PubMed ID: 26265409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of fractalkine and mobilisation of CD34
    Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
    Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
    Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
    Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.
    Hsu E; Shi H; Jordan RM; Lyons-Weiler J; Pilewski JM; Feghali-Bostwick CA
    Arthritis Rheum; 2011 Mar; 63(3):783-94. PubMed ID: 21360508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles: potential new contributors to the pathogenesis of systemic sclerosis?
    de Oliveira SM; de Azevedo Teixeira IL; França CN; de Oliveira Izar MC; Kayser C
    Adv Rheumatol; 2023 Apr; 63(1):19. PubMed ID: 37098600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
    Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
    J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
    Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis.
    Bacha NC; Blandinieres A; Rossi E; Gendron N; Nevo N; Lecourt S; Guerin CL; Renard JM; Gaussem P; Angles-Cano E; Boulanger CM; Israel-Biet D; Smadja DM
    Stem Cell Rev Rep; 2018 Apr; 14(2):223-235. PubMed ID: 29101610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.